Skip to main content
Year archive

STARPHARMA HOLDINGS LIMITED — 2025 filings

All 30 regulatory filings released by STARPHARMA HOLDINGS LIMITED (SPL) in 2025, sourced directly from the official regulator.

30 Filings
2025 Period
2025 filings (30)
Filing Released Lang
Notification regarding unquoted securities - SPL 6 pages 19.4KB
Share Issue/Capital Change
2025-12-16 English
Change of Director's Interest Notice - C Maley 2 pages 328.1KB
Director's Dealing
2025-12-16 English
AGM Chair address and CEO presentation 35 pages 4.3MB
AGM Information
2025-11-13 English
Results of 2025 Annual General Meeting 2 pages 175.9KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 6 pages 746.9KB
Interim / Quarterly Report
2025-10-27 English
Upfront payment of USD $5.5 million received from Genentech 2 pages 614.5KB
Capital/Financing Update
2025-10-21 English
Change of Director's Interest Notice - R Thomas 2 pages 306.9KB
Director's Dealing
2025-10-20 English
Australian Microcap Investment Conference presentation 27 pages 2.8MB
Investor Presentation
2025-10-20 English
Notice of 2025 Annual General Meeting/Proxy Form 22 pages 1.2MB
AGM Information
2025-10-12 English
Notification of cessation of securities - SPL 4 pages 14.8KB
Major Shareholding Notification
2025-10-05 English
Change of Director's Interest Notice - C Maley 2 pages 325.2KB
Director's Dealing
2025-10-05 English
Starpharma Announces License Agreement with Genentech 3 pages 208.4KB
Capital/Financing Update
2025-09-21 English
Presentation to Accompany License Agreement with Genentech 8 pages 493.7KB
Investor Presentation
2025-09-21 English
Date of Annual General Meeting 2025 1 page 174.2KB
AGM Information
2025-09-16 English
$3.7M R&D Tax Incentive Received 1 page 129.8KB
Regulatory Filings
2025-08-27 English
2025 Appendix 4E Preliminary Financial Report 1 pag
Interim / Quarterly Report
2025-08-25 English
2025 Annual Report 88 pages 4.1MB
Annual Report
2025-08-25 English
FY25 Key Financial Results and Annual Report 2 pages 615.6KB
Annual Report
2025-08-25 English
2025 Appendix 4G and Corporate Governance Statement 22 pages 3.1MB
Regulatory Filings
2025-08-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 734.9KB
Interim / Quarterly Report
2025-07-30 English
Notification of cessation of securities - SPL 4 pages 14.8KB
Regulatory Filings
2025-07-07 English
Change in substantial holding 5 pages 611.6KB
Major Shareholding Notification
2025-06-03 English
Change in substantial holding 4 pages 151.9KB
Major Shareholding Notification
2025-06-02 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 724.1KB
Interim / Quarterly Report
2025-04-29 English
Application for quotation of securities - SPL 6 pages 18.3KB
Share Issue/Capital Change
2025-04-03 English
Notification of cessation of securities - SPL 4 pages 14.8KB
Regulatory Filings
2025-04-03 English
Becoming a substantial holder 4 pages 152.6KB
Director's Dealing
2025-03-16 English
Half Yearly Report and Accounts 21 pages 2.5MB
Interim / Quarterly Report
2025-02-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 302.9KB
Interim / Quarterly Report
2025-01-28 English
DEP Presentation at Targeted Radio Therapies Conference 28 pages 2.7MB
Investor Presentation
2025-01-15 English